RKI-1313

CAS No. 1342276-76-9

RKI-1313( RKI-1313 | RKI 1313 | RKI1313 )

Catalog No. M11371 CAS No. 1342276-76-9

RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 329 In Stock
5MG 555 In Stock
10MG 791 In Stock
25MG 1197 In Stock
50MG 1611 In Stock
100MG 2151 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RKI-1313
  • Note
    Research use only, not for human use.
  • Brief Description
    RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
  • Description
    RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RKI-1313 | RKI 1313 | RKI1313
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    ROCK1| ROCK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1342276-76-9
  • Formula Weight
    340.4
  • Molecular Formula
    C17H16N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C(NC1=NC(C2=CC=NC=C2)=CS1)NCC3=CC=CC(OC)=C3
  • Chemical Name
    1-(3-Methoxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patel RA, et al. Y Res. 2012 Oct 1;72(19): 5025-34.
molnova catalog
related products
  • CLINODISIDE A

    Clinodiside A in rats with one compartment open model into the body, rapid distribution, elimination rate.

  • SAR407899 hydrochlor...

    SAR407899 hydrochloride is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.

  • Narciclasine

    Narciclasine, a natural product, modulates the Rho/Rho-kinase/LIM kinase/cofilin signaling pathway, greatly increasing GTPase RhoA activity.